Guidelines for Antimicrobial Use in Dogs and Cats

Guide to Antimicrobial Use in Animals

Volumn , Issue , 2009, Pages 183-206

  Guardabassi, Luca ^a   Houser, Geoffrey A ^a   Frank, Linda A ^b   Papich, Mark G ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TENNESSEE   (United States)

^c Department of Veterinary Anatomy amp Public Health   (United States)

Author keywords

'best guess' approach based on microscopy and appropriate pathogen targeting drugs; Antimicrobials for systemic use for dogs, cats and humans; Canine pyoderma and antimicrobial use in small animal practice; Cytology to guide antimicrobial choice; Guidance on prudent antimicrobial use lacking in small animal practice; Multi resistant bacteria in pet animals; Multi resistant E. coli with extended spectrum lactamase (ESBL) activity; Occurrence of MRSA in dogs and cats; Topical antibacterial options for treatment of otitis; Using antimicrobials in prudent and rational manner without clinical outcome consequences

Indexed keywords

EID: 84889342017     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444302639.ch11     Document Type: Chapter

References (89)

1. Holso, K., Rantala, M., Lillas, A., et al. (2005). Prescribing antimicrobial agents for dogs and cats via university pharmacies in Finland-patterns and quality of information. Acta Vet. Scand. 46: 87-93.
2. SVARM (2005). Swedish veterinary antimicrobial resistance monitoring. The National Veterinary Institute (SVA), Uppsala, Sweden, 2006. Available at: www.sva.se.
3. DANMAP (2005). Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. ISSN 1600-2032 (www.danmap.org).
4. Holm, B.R., Petersson, U., Morner, A., et al. (2002). Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet. Rec. 151: 600-5.
5. Ogeer-Gyles, J., Mathews, K.A., Sears, W., et al. (2006). Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit. J. Am. Vet. Med. Assoc. 229: 694-9.
6. Trott, D.J., Filippich, L.J., Bensink, J.C. et al. (2004). Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. J. Med. Microbiol. 53: 439-3.
7. Guardabassi, L., Schwarz, S. and Lloyd, D.H. (2004). Pet animals as reservoirs of antimicrobial-resistant bacteria. J. Antimicrob. Chemother. 54: 321-32.
8. Pak, S.I., Han, H.R. and Shimizu, A. (1999). Characterization of methicillin-resistant Staphylococcus aureus isolated from dogs in Korea. J. Vet. Med. Sci. 61: 1013-8.
9. Owen, M.R., Moores, A.P. and Coe, R.J. (2004). Management of MRSA septic arthritis in a dog using a gentamicin-impregnated collagen sponge. J. Small Anim. Pract. 45: 609-12.
10. van Duijkeren, E., Box, A.T., Heck, M.E., et al. (2004). Methicillin-resistant staphylococci isolated from animals. Vet. Microbiol. 103: 91-97.
11. Morris, D.O., Mauldin, E.A., O'Shea, K., et al. (2006). Clinical, microbiological, and molecular characterization of methicillin-resistant Staphylococcus aureus infections of cats. Am. J. Vet. Res. 67: 1421-5.
12. Loeffler, A., Boag, A.K., Sung, J., et al. (2005). Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J. Antimicrob. Chemother. 56: 692-7.
13. O'Mahony, R., Abbott, Y., Leonard, F.C., et al. (2005). Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland. Vet. Microbiol. 109: 285-96.
14. Baptiste, K.E., Williams, K., Willams, N.J., et al. (2005). Methicillin-resistant staphylococci in companion animals. Emerg. Infect. Dis. 11: 1942-4.
15. Boag, A., Loeffler, A. and Lloyd, D.H. (2004). Methicillinresistant Staphylococcus aureus in small animal practice. Vet. Rec. 154: 366.
16. Strommenger, B., Kehrenberg, C., Kettlitz, C., et al. (2006). Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J. Antimicrob. Chemother. 57: 461-5.
17. Hanselman, B.A., Kruth, S.A., Rousseau, J., et al. (2006). Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel. Emerg. Infect. Dis. 12: 1933-8.
18. Moodley, A., Nightingale, E.C., Stegger, M., et al. (2008). High risk for nasal carriage of methicillin resistant Staphylococcus aureus among Danish veterinary practioners. Scand. J. Work Environ. Health 34: (in Press).
19. Moodley, A., Stegger, M., Bagcigil, F., et al. (2006). PFGE and spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland. J. Antimicrob. Chemother. 56: 692-7.
20. Weese, J.S., Dick, H., Willey, B.M., et al. (2006). Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet. Microbiol. 115: 148-55.
21. Rankin, S., Roberts, S., O'Shea, K., et al. (2005). Panton-Valentine leukocidin (PVL) toxin positive MRSA strains isolated from companion animals. Vet. Microbiol. 108: 145-8.
22. Malik, L., Coombs, G.W., O'Brien, F.G., et al. (2006). Molecular typing of methicillin-resistant staphylococci isolated from cats and dogs. J. Antimicrob. Chemother. 58: 428-31.
23. Boost, M.V., O'donoghue, M.M., Siu, K.H., et al. (2007). Characterisation of methicillin-resistant Staphylococcus aureus isolates from dogs and their owners. Clin. Microbiol. Infect. 13: 731-733.
24. Manian, F.A. (2003). Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin. Infect. Dis. 36: 26-8.
25. van Duijkeren, E., Wolfhagen, M.J., Heck, M.E. and Wannet, W.J. (2005). Transmission of a Panton-Valentine leucocidin-positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J. Clin. Microbiol. 43: 6209-11.
26. van Duijkeren, E., Box, A.T.A., Mulder, J., et al. (2003). Methicillin resistant Staphylococcus aureus (MRSA) infection in a dog in the Netherlands. Tijdschrift voor Diergeneeskunde 128: 314-5.
27. Vitale, C.B., Gross, T.L. and Weese, J.S. (2006). Methicillinresistant Staphylococcus aureus in cat and owner. Emerg. Infect. Dis. 12: 1998-2000.
28. Lloyd, D.H., Lamport, A.I., Noble, W.C., et al. (1999). Fluoroquinolone resistance in Staphylococcus intermedius. Vet. Dermatol. 10: 249-51.
29. Cohn, L.A., Gary, A.T., Fales, W.H., et al. (2003). Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J. Vet. Diag. Invest. 15: 338-43.
30. Ganiere, J.P., Medaille, C., Limet, A., et al. (2001). Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet. Dermatol. 12: 171-5.
31. Authier, S., Paquette, D., Labrecque, O. and Messier, S. (2006). Comparison of susceptibility to antimicrobials of bacterial isolates from companion animals in a veterinary diagnostic laboratory in Canada between 2 time points 10 years apart. Can. Vet. J. 47: 774-8.
32. Jones, R.D., Kania, S.A., Rohrbach, B.W., et al. (2007). Prevalence of oxacillin-and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J. Am. Vet. Med. Assoc. 230: 221-7.
33. Gortel, K., Campbell, K.L., Kakoma, I., et al. (1999). Methicillin resistance among staphylococci isolated from dogs. Am. J. Vet. Res. 60: 1526-30.
34. Zubeir, I.E., Kanbar, T., Alber, J., et al. (2007). Phenotypic and genotypic characteristics of methicillin/oxacillinresistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet. Microbiol. 121: 170-6.
35. Vengust, M., Anderson, M.E., Rousseau, J., et al. (2006). Methicillin-resistant staphylococcal colonization in clinically normal dogs and horses in the community. Lett. Appl. Microbiol. 43: 602-6.
36. Kania, S.A., Williamson, N.L., Frank, L.A., et al. (2004). Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. Am. J. Vet. Res. 65: 1265-8.
37. SVARM (2006). Swedish veterinary antimicrobial resistance monitoring. The National Veterinary Institute (SVA), Uppsala, Sweden, 2006. Available at: www.sva.se.
38. Loeffler, A., Linek, M., Moodley, A., et al. (2007). First report of multi-resistant, mecA-Positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 18: 412-421.
39. Bannoehr, J., Ben Zakour, N.L., Waller, A.S., et al. (2007). Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emegency of methicillin-resistant strains. J. Bacteriol. 189: 8685-92.
40. Frank, L.A., Kania, S.A., Hnilica, K.A., et al. (2003). Isolation of Staphylococcus schleiferi from dogs with pyoderma. J. Am. Vet. Med. Assoc. 222: 451-4.
41. Morris, D.O., Rook, K.A., Shofer, F.S. and Rankin, S.C. (2006). Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Vet. Dermatol. 17(5): 332-7.
42. Sasaki, T., Kikuchi, K., Tanaka, Y., et al. (2007). Methicillinresistant Staphylococcus pseudintermedius in a veterinary teaching hospital. J. Clin. Microbiol. 45: 1118-25.
43. Teshager, T., Dominguez, L., Morenzo, M.A., et al. (2000). Isolation of an SHV-12 β-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections. Antimicrob. Agents. Chemother. 44: 3483-4.
44. Warren, A., Townsend, K., King, T., et al. (2001). Multi-drug resistant Escherichia coli with extendedspectrum β-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs. Aust. Vet. J. 79(9): 621-3.
45. Oluoch, A.O., Kim, C.H., Weisiger, R.M., et al. (2001). Nonenteric Escherichia coli isolates from dogs: 674 cases (1990-1998). J. Am. Vet. Med. Assoc. 218: 381-4.
46. Cooke, C.L., Singer, R.S., Jang, S.S. et al. (2002). Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J. Am. Vet. Med. Assoc. 220: 190-2.
47. Féria, C., Ferreira, E., Correia, J.D., et al. (2002). Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J. Antimicrob. Chemother. 49: 77-85.
48. Ogeer-Gyles, J., Mathews, K., Weese, J.S., et al. (2006). Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters. J. Am. Vet. Med. Assoc. 229: 1584-90.
49. Sanchez, S., Stevenson, M.A.M., Hudson, C.R., et al. (2002). Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 40: 3586-95.
50. Carattoli, A., Lovari, S., Franco, A., et al. (2005). Extendedspectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob. Agents Chemother. 49: 833-5.
51. Johnson, J.R., Stell, A.L., Delavari, P., et al. (2001). Phylogenetic and pathotypic similarities between Escherichia coli isolates from urinary tract infections in dogs and extraintestinal infections in humans. J. Infect. Dis. 183: 897-906.
52. Starcic, M., Johnson, J.R., Stell, A.L., et al. (2002). Haemolytic Escherichia coli isolated from dogs with diarrhea have characteristics of both uropathogenic and necrotoxigenic strains. Vet. Microbiol. 85: 361-77.
53. Williamson, N.L., Frank, L.A. and Hnilica, K.A. (2002). Effects of short-term trimethoprim-sulfamethoxazole administration on thyroid function in dogs. J. Am. Vet. Med. Assoc. 221: 802-6.
54. Frank, L.A., Hnilica, K.A., May, E.R., et al. (2005). Effects of sulfamethoxazole-trimethoprim on thyroid function in dogs. Am. J. Vet. Res. 66: 256-9.
55. Bidgood, T.L. and Papich, M.G. (2003). Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. Am. J. Vet. Res. 64: 1040-6.
56. Bettenay, S.V., Mueller, R.S. and Dell'Osa, D. (1998). Doxycycline hydrochloride in the treatment of canine pyoderma. Aust. Vet. Practit. 28: 14-19.
57. Koch, H.J. and Vercelli, A. (1993). Shampoos and other topical therapies. In: Advances in Veterinary Dermatology, Volume 2 (eds. Ihrke, P.J., Mason, I.S. and White, S.D.). Pergamon Press, New York, pp. 409-11.
58. Cole, L.K., Papich, M.G., Kwochka, K.W., et al. (2005). Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa. In: Proceedings of North American Veterinary Dermatology Forum 20: 182.
59. Foster, A.P. and DeBoer, D.J. (1998). The role of Pseudomonas in canine ear disease. Compendium Small Anim. Pract. 20: 909-19.
60. Cole, L.K., Kwochka, K.W., Kowalski, J.J., et al. (1998). Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. J. Am. Vet. Med. Assoc. 212: 534-8.
61. Martín Barrasa, J.L., Lupiola Gómez, P., González Lama, Z. and Tejedor Junco, M.T. (2000). Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. J. Vet. Med. Ser. B 47: 191-6.
62. Seol, B., Naglic, T., Madic, J. and Bedekovic, M. (2002). In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents. J. Vet. Med. Ser. B 49: 188-2.
63. Brothers, A.M., Gibbs, P.S. and Wooley, R.E. (2002). Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro. Vet. Ther. 3: 493-500.
64. Tejedor, M.T., Martin, J.L., Navia, M., et al. (2003). Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections. Vet. Microbiol. 94: 295-301.
65. Ashworth, C.D. and Nelson, D.R. (1990). Antimicrobial potentiation of irrigation solutions containing tris-[hydroxymethyl] aminomethane-EDTA. J. Am. Vet. Med. Assoc. 197: 1513-4.
66. Sparks, T.A., Kemp, D.T., Wooley, R.E., et al. (1994). Antimicrobial effect of combinations of EDTA-tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs. Vet. Res. Commun. 18: 241-249.
67. Farca, A.M., Piromalli, G., Maffei, F., et al. (1997). Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis. J. Small Anim. Pract. 38: 243-5.
68. NCCLS (1998). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Proposed standard. NCCLS document M31-A. Villanova, PA: National Committee for Clinical Laboratory Standards.
69. Frimodt-Møller, N. (2002). Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int. J. Antimicrob. Agents 19: 546-53.
70. Hagman, R. and Greko, C. (2005). Antimicrobial resistance in Escherichia coli isolated from bitches with pyometra and from urine samples from other dogs. Vet. Rec. 157: 193-6.
71. Pedersen, K., Pedersen, K., Jensen, H., et al. (2007). Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J. Antimicrob. Chemother. 60: 775-81.
72. Meares, E.M. (1982). Prostatitis: review of pharmacokinetics and therapy. Rev. Infect. Dis. 4: 475-83.
73. Happonen, I., Linden, J., Saari, S., et al. (1998). Detection and effects of helicobacters in healthy dogs and dogs with signs of gastritis. J. Am. Vet. Med. Assoc. 213: 1767-74.
74. Wiinberg, B., Spohr, A., Dietz, H.H., et al. (2005). Quantitative analysis of inflammatory and immune responses in dogs with gastritis and their relationship to Helicobacter spp. infection. J. Vet. Intern. Med. 19: 4-14.
75. Happonen, I., Linden, J. and Westermarck, E. (2000). Effect of triple therapy on eradication of canine gastric helicobacters and gastric disease. J. Small Anim. Pract. 41: 1-6.
76. Watson, A.D.J. and Maddison, J.E. (2001). Systemic antibacterial drug use in dogs in Australia. Aust. Vet. J. 79: 740-6.
77. Westermarck, E., Skrzypczak, T., Harmoinen, J., et al. (2005). Tylosin-responsive chronic diarrhea in dogs. J. Vet. Intern. Med. 19: 177-186.
78. Johnston, K.L., Lamport, A.I., Ballevre, O.P. and Batt, R.M. (2000). Effects of oral administration of metronidazole on small intestinal bacteria and nutrients of cats. Am. J. Vet. Res. 61: 1106-12.
79. Speakman, A.J., Dawson, S., Corkill, J.E., et al. (2000). Antibiotic susceptibility of canine Bordetella bronchiseptica isolates. Vet. Microbiol. 71: 193-200.
80. Streppa, H.K., Singer, M.J. and Budsberg, S.C. (2001). Applications of local antimicrobial delivery systems in veterinary medicine. J. Am. Vet. Med. Assoc. 219: 40-8.
81. Rahal, J.J. and Simberkoff, M.S. (1979). Bactericidal and bacteriostatic action of chloramphenicol against meningeal pathogens. Antimicrob. Agents Chemother. 16: 13-8.
82. Greene, C.E. and Dearmin, M.G. (2006). Surgical and traumatic wound infections. In: Infectious Diseases of the Dog and the Cat, 3rd edn (ed. Greene, C.E.). Saunders Elsevier, St. Louis, Missouri, pp. 935-61.
83. Lloyd, D.H., Lamport, A.I. and Feeney, C. (1996). Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the UK, 1980-96. Vet. Dermatol. 7: 171-5.
84. Myllyniemi, A.L., Gindonis, V., Nykäsenoja, S. and Koppinen, J. (2004). FINRES-Vet 2002-2003, Finnish Veterinary Antimicrobial Resistance Monitoring and Consumption of Antimicrobial Agents. National Veterinary and Food Research Institute, Helsinki, Finland.
85. Wissing, A., Nicolet, J. and Boerlin, P. (2001). Antimicrobial resistance situation in Swiss veterinary medicine. Schweizer Archiv fur Tierheilkunde 143: 503-10.
86. Hartmann, F.A., White, D.G., West, S.E., et al. (2005). Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Vet. Microbiol. 108: 119-31.
87. Strain, G.M., Merchant, S.R., Neer, M. and Tedford, B.L. (1995). Ototoxicity assessment of a gentamicin sulfate otic preparation in dogs. Am. J. Vet. Res. 56: 532-8.
88. Barsanti, J.A. (2006). Genitourinary infections. In: Infectious Diseases of the Dog and the Cat, 3rd Edn (ed. Greene, C.E.). Saunders Elsevier, St. Louis, Missouri, pp. 935-61.
89. Papich, M.G. (2007). Saunders Handbook of Veterinary Drugs, 2nd Edn. Saunders/Elsevier St. Louis Missouri, USA.